Skip to main content

JAK2, MPL, and CALR mutations in children with essential thrombocythemia

This is a preview of subscription content, access via your institution.

Fig. 1

References

  1. Fu R, Zhang L, Yang R. Paediatric essential thrombocythemia: clinical and molecular features, diagnosis and treatment. Br J Haematol. 2013;163(3):295–302.

    Article  PubMed  Google Scholar 

  2. Rumi E, Pietra D, Ferretti V, Klampfl T, Harutyunyan AS, Milosevic JD, et al. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 2014;123(10):1544–51.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. Giona F, Teofili L, Capodimonti S, Laurino M, Martini M, Marzella D, et al. CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence. Blood. 2014;123(23):3677–9.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Akira Shimada.

Ethics declarations

Conflict of interest

There are no relevant conflicts of interest to disclose.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 1595 kb)

Supplementary material 2 (DOCX 17 kb)

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sekiya, Y., Okuno, Y., Muramatsu, H. et al. JAK2, MPL, and CALR mutations in children with essential thrombocythemia. Int J Hematol 104, 266–267 (2016). https://doi.org/10.1007/s12185-016-2022-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-016-2022-2

Keywords

  • Pediatric Patient
  • Somatic Mutation
  • Essential Thrombocythemia
  • Myelofibrosis
  • Adult Cohort